ID   RTN4_RAT                Reviewed;        1163 AA.
AC   Q9JK11; Q9JK10; Q9R0D9; Q9WUE9; Q9WUF0;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   02-OCT-2024, entry version 166.
DE   RecName: Full=Reticulon-4;
DE   AltName: Full=Foocen;
DE   AltName: Full=Glut4 vesicle 20 kDa protein;
DE   AltName: Full=Neurite outgrowth inhibitor;
DE            Short=Nogo protein;
GN   Name=Rtn4; Synonyms=Nogo;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C), AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=Sprague-Dawley; TISSUE=Adipocyte;
RX   PubMed=10231557; DOI=10.1016/s0167-4889(99)00033-6;
RA   Morris N.J., Ross S.A., Neveu J.M., Lane W.S., Lienhard G.E.;
RT   "Cloning and characterization of a 22 kDa protein from rat adipocytes: a
RT   new member of the reticulon family.";
RL   Biochim. Biophys. Acta 1450:68-76(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND C).
RX   PubMed=10667796; DOI=10.1038/35000219;
RA   Chen M.S., Huber A.B., Van der Haar M.E., Frank M., Schnell L.,
RA   Spillmann A.A., Christ F., Schwab M.E.;
RT   "Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen
RT   for monoclonal antibody IN-1.";
RL   Nature 403:434-439(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS B AND B2).
RC   STRAIN=Wistar Kyoto; TISSUE=Vascular smooth muscle;
RA   Ito T., Schwartz S.M.;
RT   "Cloning of a member of the reticulon gene family in rat: one of two minor
RT   splice variants.";
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=12037567; DOI=10.1038/417547a;
RA   GrandPre T., Li S., Strittmatter S.M.;
RT   "Nogo-66 receptor antagonist peptide promotes axonal regeneration.";
RL   Nature 417:547-551(2002).
RN   [5]
RP   INTERACTION WITH CNTNAP1.
RX   PubMed=14592966; DOI=10.1093/emboj/cdg570;
RA   Nie D.-Y., Zhou Z.-H., Ang B.-T., Teng F.Y.H., Xu G., Xiang T., Wang C.-Y.,
RA   Zeng L., Takeda Y., Xu T.-L., Ng Y.K., Faivre-Sarrailh C., Popko B.,
RA   Ling E.-A., Schachner M., Watanabe K., Pallen C.J., Tang B.L., Xiao Z.-C.;
RT   "Nogo-A at CNS paranodes is a ligand of Caspr: possible regulation of K(+)
RT   channel localization.";
RL   EMBO J. 22:5666-5678(2003).
RN   [6]
RP   FUNCTION (ISOFORM A).
RX   PubMed=12843238; DOI=10.1523/jneurosci.23-13-05393.2003;
RA   Oertle T., van der Haar M.E., Bandtlow C.E., Robeva A., Burfeind P.,
RA   Buss A., Huber A.B., Simonen M., Schnell L., Brosamle C., Kaupmann K.,
RA   Vallon R., Schwab M.E.;
RT   "Nogo-A inhibits neurite outgrowth and cell spreading with three discrete
RT   regions.";
RL   J. Neurosci. 23:5393-5406(2003).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-107, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [8]
RP   INTERACTION WITH ATL1.
RX   PubMed=19665976; DOI=10.1016/j.cell.2009.05.025;
RA   Hu J., Shibata Y., Zhu P.-P., Voss C., Rismanchi N., Prinz W.A.,
RA   Rapoport T.A., Blackstone C.;
RT   "A class of dynamin-like GTPases involved in the generation of the tubular
RT   ER network.";
RL   Cell 138:549-561(2009).
RN   [9]
RP   FUNCTION (ISOFORM A).
RX   PubMed=20573699; DOI=10.1242/dev.048371;
RA   Petrinovic M.M., Duncan C.S., Bourikas D., Weinman O., Montani L.,
RA   Schroeter A., Maerki D., Sommer L., Stoeckli E.T., Schwab M.E.;
RT   "Neuronal Nogo-A regulates neurite fasciculation, branching and extension
RT   in the developing nervous system.";
RL   Development 137:2539-2550(2010).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-329; SER-333;
RP   SER-425; THR-429; SER-689; SER-766; SER-830; THR-832 AND SER-922, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Required to induce the formation and stabilization of
CC       endoplasmic reticulum (ER) tubules. They regulate membrane
CC       morphogenesis in the ER by promoting tubular ER production. They
CC       influence nuclear envelope expansion, nuclear pore complex formation
CC       and proper localization of inner nuclear membrane proteins. However
CC       each isoform have specific functions mainly depending on their tissue
CC       expression specificities. {ECO:0000305}.
CC   -!- FUNCTION: [Isoform A]: Developmental neurite growth regulatory factor
CC       with a role as a negative regulator of axon-axon adhesion and growth,
CC       and as a facilitator of neurite branching. Regulates neurite
CC       fasciculation, branching and extension in the developing nervous
CC       system. Involved in down-regulation of growth, stabilization of wiring
CC       and restriction of plasticity in the adult CNS (PubMed:12037567,
CC       PubMed:12843238, PubMed:20573699). Regulates the radial migration of
CC       cortical neurons via an RTN4R-LINGO1 containing receptor complex. Acts
CC       as a negative regulator of central nervous system angiogenesis.
CC       Inhibits spreading, migration and sprouting of primary brain
CC       microvascular endothelial cells (MVECs). Also induces the retraction of
CC       MVECs lamellipodia and filopodia in a ROCK pathway-dependent manner (By
CC       similarity). {ECO:0000250|UniProtKB:Q99P72,
CC       ECO:0000269|PubMed:12037567, ECO:0000269|PubMed:12843238,
CC       ECO:0000269|PubMed:20573699}.
CC   -!- FUNCTION: [Isoform B]: Mainly function in endothelial cells and
CC       vascular smooth muscle cells, is also involved in immune system
CC       regulation (By similarity). Modulator of vascular remodeling, promotes
CC       the migration of endothelial cells but inhibits the migration of
CC       vascular smooth muscle cells. Regulates endothelial sphingolipid
CC       biosynthesis with direct effects on vascular function and blood
CC       pressure. Inhibits serine palmitoyltransferase, SPTLC1, the rate-
CC       limiting enzyme of the novo sphingolipid biosynthetic pathway, thereby
CC       controlling production of endothelial sphingosine-1-phosphate (S1P).
CC       Required to promote macrophage homing and functions such as
CC       cytokine/chemokine gene expression involved in angiogenesis,
CC       arteriogenesis and tissue repair. Mediates ICAM1 induced
CC       transendothelial migration of leukocytes such as monocytes and
CC       neutrophils and acute inflammation. Necessary for immune responses
CC       triggered by nucleic acid sensing TLRs, such as TLR9, is required for
CC       proper TLR9 location to endolysosomes. Also involved in immune response
CC       to LPS. Plays a role in liver regeneration through the modulation of
CC       hepatocytes proliferation (By similarity). Reduces the anti-apoptotic
CC       activity of Bcl-xl and Bcl-2. This is likely consecutive to their
CC       change in subcellular location, from the mitochondria to the
CC       endoplasmic reticulum, after binding and sequestration. With isoform C,
CC       inhibits BACE1 activity and amyloid precursor protein processing (By
CC       similarity). {ECO:0000250|UniProtKB:Q99P72,
CC       ECO:0000250|UniProtKB:Q9NQC3}.
CC   -!- FUNCTION: [Isoform C]: Regulates cardiomyocyte apoptosis upon hypoxic
CC       conditions (By similarity). With isoform B, inhibits BACE1 activity and
CC       amyloid precursor protein processing (By similarity).
CC       {ECO:0000250|UniProtKB:Q99P72, ECO:0000250|UniProtKB:Q9NQC3}.
CC   -!- SUBUNIT: Binds to RTN4R (By similarity). Interacts with ATL1
CC       (PubMed:19665976). Interacts with TMEM170A (By similarity). Interacts
CC       with RTN4IP1 (By similarity). {ECO:0000250|UniProtKB:Q99P72,
CC       ECO:0000250|UniProtKB:Q9NQC3, ECO:0000269|PubMed:19665976}.
CC   -!- SUBUNIT: [Isoform A]: Interacts in trans with CNTNAP1
CC       (PubMed:14592966). Interacts with REEP5 (By similarity). Interacts with
CC       synaptic plasticity regulator PANTS; the interaction results in
CC       enhanced RTN4-mediated inhibition of AMPA receptor clustering (By
CC       similarity). Interacts with GPR50 (By similarity).
CC       {ECO:0000250|UniProtKB:Q9NQC3, ECO:0000269|PubMed:14592966}.
CC   -!- SUBUNIT: [Isoform B]: Homodimer (By similarity). Interacts with
CC       BAD/Bcl-xl and BCL2. Interact with RTN3 (By similarity). Interacts with
CC       NGBR (By similarity). Interacts with SPTLC1 (By similarity). Interacts
CC       with GRAMD4 (By similarity). Interacts with CDH5 (By similarity).
CC       Interacts with BACE1 and BACE2 (By similarity). Interacts with REEP5
CC       (By similarity). Interacts with RETREG3 (By similarity).
CC       {ECO:0000250|UniProtKB:Q99P72, ECO:0000250|UniProtKB:Q9NQC3}.
CC   -!- SUBUNIT: [Isoform C]: Interacts with BACE1 and BACE2 (By similarity).
CC       Interacts with TMEM33 (By similarity). {ECO:0000250|UniProtKB:Q9NQC3}.
CC   -!- INTERACTION:
CC       Q9JK11-1; Q6PST4: Atl1; NbExp=6; IntAct=EBI-919989, EBI-2410213;
CC       Q9JK11-1; P48722: Hspa4l; Xeno; NbExp=6; IntAct=EBI-919989, EBI-8314699;
CC       Q9JK11-1; O95136: S1PR2; Xeno; NbExp=2; IntAct=EBI-919989, EBI-10634606;
CC       Q9JK11-1; P52592: S1pr2; Xeno; NbExp=3; IntAct=EBI-919989, EBI-16091339;
CC       Q9JK11-3; Q8WXF7: ATL1; Xeno; NbExp=2; IntAct=EBI-920002, EBI-2410266;
CC   -!- SUBCELLULAR LOCATION: [Isoform A]: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9NQC3}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell membrane {ECO:0000250|UniProtKB:Q9NQC3}; Multi-pass
CC       membrane protein {ECO:0000255}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q9NQC3}. Synapse {ECO:0000250|UniProtKB:Q99P72}.
CC       Note=Anchored to the membrane of the endoplasmic reticulum (ER) through
CC       2 putative transmembrane domains. Localizes throughout the ER tubular
CC       network. Co-localizes with TMEM33 at the ER sheets.
CC       {ECO:0000250|UniProtKB:Q9NQC3}.
CC   -!- SUBCELLULAR LOCATION: [Isoform B]: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9NQC3}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell membrane {ECO:0000250|UniProtKB:Q9NQC3}; Multi-pass
CC       membrane protein {ECO:0000255}; Extracellular side
CC       {ECO:0000250|UniProtKB:Q9NQC3}. Cell junction
CC       {ECO:0000250|UniProtKB:Q9NQC3}. Note=Mainly located on endoplasmic
CC       reticulum tubules and sheet edges. Upon ICAM1 engagement, redistributed
CC       toward endothelial junctions where interacts with CDH5.
CC       {ECO:0000250|UniProtKB:Q9NQC3}.
CC   -!- SUBCELLULAR LOCATION: [Isoform C]: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9NQC3}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=A; Synonyms=Nogo-A, NI-220-250;
CC         IsoId=Q9JK11-1; Sequence=Displayed;
CC       Name=B; Synonyms=Nogo-B, Foocen-M1;
CC         IsoId=Q9JK11-2; Sequence=VSP_005658;
CC       Name=C; Synonyms=Nogo-C, VP20;
CC         IsoId=Q9JK11-3; Sequence=VSP_005656, VSP_005657;
CC       Name=B2; Synonyms=Foocen-M2;
CC         IsoId=Q9JK11-4; Sequence=VSP_005659;
CC   -!- TISSUE SPECIFICITY: Isoforms A, B and C are present in optic nerve,
CC       spinal cord and cerebral cortex. Isoforms A and B are present in dorsal
CC       root ganglion, sciatic nerve and PC12 cells after longer exposure.
CC       Isoforms B and C are detected in kidney, cartilage, skin, lung and
CC       spleen. Isoform C is expressed at high level in skeletal muscle. In
CC       adult animals isoform A is expressed mainly in the nervous system.
CC   -!- DOMAIN: Three regions, residues 59-172, 544-725 and the loop 66 amino
CC       acids, between the two transmembrane domains, known as Nogo-66 loop,
CC       appear to be responsible for the inhibitory effect on neurite outgrowth
CC       and the spreading of neurons. This Nogo-66 loop, mediates also the
CC       binding of RTN4 to its receptor. {ECO:0000269|PubMed:12037567}.
CC   -!- DOMAIN: [Isoform B]: N-terminal part, called Am-Nogo-B(1-200), is the
CC       functional domain for RTN4B-mediated signaling in endothelial and
CC       vascular smooth muscle cells. {ECO:0000250|UniProtKB:Q9NQC3}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Nerve regrowth: nipped by a
CC       no-go - Issue 69 of April 2006;
CC       URL="https://web.expasy.org/spotlight/back_issues/069";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF051335; AAF01564.1; -; mRNA.
DR   EMBL; AJ242961; CAB71027.1; -; mRNA.
DR   EMBL; AJ242962; CAB71028.1; -; mRNA.
DR   EMBL; AJ242963; CAB71029.1; -; mRNA.
DR   EMBL; AF132045; AAD31019.1; -; mRNA.
DR   EMBL; AF132046; AAD31020.1; -; mRNA.
DR   RefSeq; NP_114019.1; NM_031831.1.
DR   RefSeq; XP_006251670.2; XM_006251608.2. [Q9JK11-2]
DR   RefSeq; XP_006251671.1; XM_006251609.3. [Q9JK11-3]
DR   RefSeq; XP_017454882.1; XM_017599393.1. [Q9JK11-4]
DR   AlphaFoldDB; Q9JK11; -.
DR   BMRB; Q9JK11; -.
DR   SMR; Q9JK11; -.
DR   BioGRID; 249825; 7.
DR   DIP; DIP-37179N; -.
DR   IntAct; Q9JK11; 17.
DR   MINT; Q9JK11; -.
DR   STRING; 10116.ENSRNOP00000006443; -.
DR   iPTMnet; Q9JK11; -.
DR   PhosphoSitePlus; Q9JK11; -.
DR   jPOST; Q9JK11; -.
DR   PaxDb; 10116-ENSRNOP00000006443; -.
DR   ABCD; Q9JK11; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000042965.4; ENSRNOP00000040760.2; ENSRNOG00000004621.9. [Q9JK11-3]
DR   GeneID; 83765; -.
DR   KEGG; rno:83765; -.
DR   UCSC; RGD:620989; rat. [Q9JK11-1]
DR   AGR; RGD:620989; -.
DR   CTD; 57142; -.
DR   RGD; 620989; Rtn4.
DR   VEuPathDB; HostDB:ENSRNOG00000004621; -.
DR   eggNOG; KOG1792; Eukaryota.
DR   GeneTree; ENSGT00940000156568; -.
DR   HOGENOM; CLU_048580_0_0_1; -.
DR   InParanoid; Q9JK11; -.
DR   OMA; DGQKKHW; -.
DR   OrthoDB; 7284at2759; -.
DR   PhylomeDB; Q9JK11; -.
DR   Reactome; R-RNO-193634; Axonal growth inhibition (RHOA activation).
DR   PRO; PR:Q9JK11; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000004621; Expressed in quadriceps femoris and 19 other cell types or tissues.
DR   ExpressionAtlas; Q9JK11; baseline and differential.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; ISS:UniProtKB.
DR   GO; GO:0042995; C:cell projection; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0071782; C:endoplasmic reticulum tubular network; ISO:RGD.
DR   GO; GO:0098826; C:endoplasmic reticulum tubular network membrane; ISS:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005635; C:nuclear envelope; ISS:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0007413; P:axonal fasciculation; IDA:UniProtKB.
DR   GO; GO:0001825; P:blastocyst formation; ISO:RGD.
DR   GO; GO:0007420; P:brain development; IBA:GO_Central.
DR   GO; GO:0060317; P:cardiac epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0120078; P:cell adhesion involved in sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:0035441; P:cell migration involved in vasculogenesis; ISS:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; ISS:UniProtKB.
DR   GO; GO:0022009; P:central nervous system vasculogenesis; ISS:UniProtKB.
DR   GO; GO:0021801; P:cerebral cortex radial glia-guided migration; ISS:UniProtKB.
DR   GO; GO:0071787; P:endoplasmic reticulum tubular network formation; ISS:UniProtKB.
DR   GO; GO:1990809; P:endoplasmic reticulum tubular network membrane organization; ISS:UniProtKB.
DR   GO; GO:0071786; P:endoplasmic reticulum tubular network organization; ISS:UniProtKB.
DR   GO; GO:0090156; P:intracellular sphingolipid homeostasis; ISO:RGD.
DR   GO; GO:0002523; P:leukocyte migration involved in inflammatory response; ISS:UniProtKB.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:1902430; P:negative regulation of amyloid-beta formation; ISS:UniProtKB.
DR   GO; GO:0030517; P:negative regulation of axon extension; IDA:UniProtKB.
DR   GO; GO:0050771; P:negative regulation of axonogenesis; IDA:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISO:RGD.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IDA:RGD.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IDA:RGD.
DR   GO; GO:0070571; P:negative regulation of neuron projection regeneration; IMP:RGD.
DR   GO; GO:2001213; P:negative regulation of vasculogenesis; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; IBA:GO_Central.
DR   GO; GO:0051292; P:nuclear pore complex assembly; ISS:UniProtKB.
DR   GO; GO:0021553; P:olfactory nerve development; IEP:RGD.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEP:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB.
DR   GO; GO:1905653; P:positive regulation of artery morphogenesis; ISS:UniProtKB.
DR   GO; GO:0033603; P:positive regulation of dopamine secretion; IMP:RGD.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; ISO:RGD.
DR   GO; GO:1905580; P:positive regulation of ERBB3 signaling pathway; ISO:RGD.
DR   GO; GO:0045687; P:positive regulation of glial cell differentiation; IDA:RGD.
DR   GO; GO:2000347; P:positive regulation of hepatocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0060907; P:positive regulation of macrophage cytokine production; ISS:UniProtKB.
DR   GO; GO:1905523; P:positive regulation of macrophage migration; ISS:UniProtKB.
DR   GO; GO:0033601; P:positive regulation of mammary gland epithelial cell proliferation; ISO:RGD.
DR   GO; GO:1902624; P:positive regulation of neutrophil migration; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:1905552; P:positive regulation of protein localization to endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0035022; P:positive regulation of Rac protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0034165; P:positive regulation of toll-like receptor 9 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0061462; P:protein localization to lysosome; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:2000172; P:regulation of branching morphogenesis of a nerve; IDA:UniProtKB.
DR   GO; GO:0051960; P:regulation of nervous system development; ISO:RGD.
DR   GO; GO:0150052; P:regulation of postsynapse assembly; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   DisProt; DP01152; -.
DR   Gene3D; 1.20.5.2480; -; 1.
DR   InterPro; IPR003388; Reticulon.
DR   InterPro; IPR046964; RTN1-4.
DR   PANTHER; PTHR45799:SF1; RETICULON-4; 1.
DR   PANTHER; PTHR45799; RETICULON-LIKE PROTEIN; 1.
DR   Pfam; PF02453; Reticulon; 1.
DR   PROSITE; PS50845; RETICULON; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell junction; Cell membrane;
KW   Direct protein sequencing; Endoplasmic reticulum; Membrane; Neurogenesis;
KW   Phosphoprotein; Reference proteome; Synapse; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..1163
FT                   /note="Reticulon-4"
FT                   /id="PRO_0000168167"
FT   TOPO_DOM        1..989
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        990..1010
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1011..1104
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1105..1125
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1126..1163
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          976..1163
FT                   /note="Reticulon"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00170"
FT   REGION          1..184
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          244..270
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          406..437
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          454..474
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        31..54
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        88..102
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        137..161
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        406..422
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC3"
FT   MOD_RES         7
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC3"
FT   MOD_RES         16
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         149
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99P72"
FT   MOD_RES         169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC3"
FT   MOD_RES         171
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99P72"
FT   MOD_RES         329
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         333
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99P72"
FT   MOD_RES         347
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99P72"
FT   MOD_RES         425
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         429
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         488
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99P72"
FT   MOD_RES         689
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         726
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99P72"
FT   MOD_RES         766
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         830
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         832
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         855
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99P72"
FT   MOD_RES         922
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         962
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC3"
FT   MOD_RES         1075
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NQC3"
FT   VAR_SEQ         1..964
FT                   /note="Missing (in isoform C)"
FT                   /evidence="ECO:0000303|PubMed:10231557,
FT                   ECO:0000303|PubMed:10667796"
FT                   /id="VSP_005656"
FT   VAR_SEQ         173..975
FT                   /note="Missing (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:10667796, ECO:0000303|Ref.3"
FT                   /id="VSP_005658"
FT   VAR_SEQ         192..975
FT                   /note="Missing (in isoform B2)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_005659"
FT   VAR_SEQ         965..975
FT                   /note="AVLSAELSKTS -> MDGQKKHWKDK (in isoform C)"
FT                   /evidence="ECO:0000303|PubMed:10231557,
FT                   ECO:0000303|PubMed:10667796"
FT                   /id="VSP_005657"
FT   CONFLICT        1130..1131
FT                   /note="Missing (in Ref. 3; AAD31020)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1163 AA;  126388 MW;  8CB894B09E94F0B6 CRC64;
     MEDIDQSSLV SSSTDSPPRP PPAFKYQFVT EPEDEEDEEE EEDEEEDDED LEELEVLERK
     PAAGLSAAAV PPAAAAPLLD FSSDSVPPAP RGPLPAAPPA APERQPSWER SPAAPAPSLP
     PAAAVLPSKL PEDDEPPARP PPPPPAGASP LAEPAAPPST PAAPKRRGSG SVDETLFALP
     AASEPVIPSS AEKIMDLMEQ PGNTVSSGQE DFPSVLLETA ASLPSLSPLS TVSFKEHGYL
     GNLSAVSSSE GTIEETLNEA SKELPERATN PFVNRDLAEF SELEYSEMGS SFKGSPKGES
     AILVENTKEE VIVRSKDKED LVCSAALHSP QESPVGKEDR VVSPEKTMDI FNEMQMSVVA
     PVREEYADFK PFEQAWEVKD TYEGSRDVLA ARANVESKVD RKCLEDSLEQ KSLGKDSEGR
     NEDASFPSTP EPVKDSSRAY ITCASFTSAT ESTTANTFPL LEDHTSENKT DEKKIEERKA
     QIITEKTSPK TSNPFLVAVQ DSEADYVTTD TLSKVTEAAV SNMPEGLTPD LVQEACESEL
     NEATGTKIAY ETKVDLVQTS EAIQESLYPT AQLCPSFEEA EATPSPVLPD IVMEAPLNSL
     LPSAGASVVQ PSVSPLEAPP PVSYDSIKLE PENPPPYEEA MNVALKALGT KEGIKEPESF
     NAAVQETEAP YISIACDLIK ETKLSTEPSP DFSNYSEIAK FEKSVPEHAE LVEDSSPESE
     PVDLFSDDSI PEVPQTQEEA VMLMKESLTE VSETVAQHKE ERLSASPQEL GKPYLESFQP
     NLHSTKDAAS NDIPTLTKKE KISLQMEEFN TAIYSNDDLL SSKEDKIKES ETFSDSSPIE
     IIDEFPTFVS AKDDSPKLAK EYTDLEVSDK SEIANIQSGA DSLPCLELPC DLSFKNIYPK
     DEVHVSDEFS ENRSSVSKAS ISPSNVSALE PQTEMGSIVK SKSLTKEAEK KLPSDTEKED
     RSLSAVLSAE LSKTSVVDLL YWRDIKKTGV VFGASLFLLL SLTVFSIVSV TAYIALALLS
     VTISFRIYKG VIQAIQKSDE GHPFRAYLES EVAISEELVQ KYSNSALGHV NSTIKELRRL
     FLVDDLVDSL KFAVLMWVFT YVGALFNGLT LLILALISLF SIPVIYERHQ VQIDHYLGLA
     NKSVKDAMAK IQAKIPGLKR KAD
//
